DOI QR코드

DOI QR Code

The hybrid perventricular closure of apical muscular ventricular septal defect with Amplatzer duct occluder

  • Kim, Soo Jin (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Huh, June (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Song, Jin Young (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Yang, Ji-Hyuk (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Jun, Tae-Gook (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kang, I-Seok (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 투고 : 2013.08.23
  • 심사 : 2012.10.24
  • 발행 : 2013.04.15

초록

Purpose: Apical muscular ventricular septal defects (MVSDs), especially in small infants, can be difficult to manage using surgical and percutaneous closure. An intraoperative perventricular procedure is a good option for closing apical MVSDs in small children with or without associated cardiac anomalies. We evaluated the results of hybrid perventricular closure of apical MVSDs performed using an Amplatzer duct occluder (ADO). Methods: We retrospectively reviewed the medical records of 5 patients who underwent hybrid perventricular closure of MVSDs with ADOs, from March 2006 to May 2011. The median patient age at the time of the procedure was 12 months (range, 25 days to 25 months), and the median body weight was 9.1 kg (range, 4.3 to 15 kg). Two patients had multiple ventricular septal defects (VSDs; additional perimembranous VSD in 1 patient and multiple MVSDs in the other) and 3 patients had associated cardiac anomalies; complete transposition of the great arteries in 1 patient and an atrial septal defect in 2 patients. All the procedures were performed on beating hearts, exception in 1 case. The ADO selected for the aortic side was at least 1 to 2 mm larger than the largest VSD in the left ventricle side. Results: The procedure was successful in all patients and each device was well positioned. During the median follow-up of 2.4 years, a small residual VSD was noted in 2 patients who had multiple VSDs and no leakage was seen in the other 3 patients. Conclusion: Perventricular closure of MVSD with an ADO is a good option for patients with apical MVSD. However, careful manipulation is important, especially in the case of small infants.

키워드

참고문헌

  1. Kitagawa T, Durham LA 3rd, Mosca RS, Bove EL. Techniques and results in the management of multiple ventricular septal defects. J Thorac Cardiovasc Surg 1998;115:848-56. https://doi.org/10.1016/S0022-5223(98)70366-6
  2. Serraf A, Lacour-Gayet F, Bruniaux J, Ouaknine R, Losay J, Petit J, et al. Surgical management of isolated multiple ventricular septal defects. Logical approach in 130 cases. J Thorac Cardiovasc Surg 1992;103:437-42.
  3. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation 1988;78:361-8. https://doi.org/10.1161/01.CIR.78.2.361
  4. Tofeig M, Patel RG, Walsh KP. Transcatheter closure of a mid-muscular ventricular septal defect with an amplatzer VSD occluder device. Heart 1999;81:438-40. https://doi.org/10.1136/hrt.81.4.438
  5. Thanopoulos BD, Tsaousis GS, Konstadopoulou GN, Zarayelyan AG. Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children. J Am Coll Cardiol 1999;33:1395-9. https://doi.org/10.1016/S0735-1097(99)00011-X
  6. Hijazi ZM, Hakim F, Al-Fadley F, Abdelhamid J, Cao QL. Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: initial results and technical considerations. Catheter Cardiovasc Interv 2000;49:167-72. https://doi.org/10.1002/(SICI)1522-726X(200002)49:2<167::AID-CCD11>3.0.CO;2-S
  7. Amin Z, Berry JM, Foker JE, Rocchini AP, Bass JL. Intraoperative closure of muscular ventricular septal defect in a canine model and application of the technique in a baby. J Thorac Cardiovasc Surg 1998;115:1374-6. https://doi.org/10.1016/S0022-5223(98)70222-3
  8. Latiff HA, Alwi M, Kandhavel G, Samion H, Zambahari R. Transcatheter closure of multiple muscular ventricular septal defects using Gianturco coils. Ann Thorac Surg 1999;68:1400-1. https://doi.org/10.1016/S0003-4975(99)00706-7
  9. Kalra GS, Verma PK, Singh S, Arora R. Transcatheter closure of ventricular septal defect using detachable steel coil. Heart 1999;82:395-6. https://doi.org/10.1136/hrt.82.3.395
  10. Pesonen E, Thilen U, Sandstrom S, Arheden H, Koul B, Olsson SE, et al. Transcatheter closure of post-infarction ventricular septal defect with the Amplatzer Septal Occluder device. Scand Cardiovasc J 2000;34:446-8. https://doi.org/10.1080/14017430050196315
  11. Fedson S, Jolly N, Lang RM, Hijazi ZM. Percutaneous closure of a ruptured sinus of Valsalva aneurysm using the Amplatzer Duct Occluder. Catheter Cardiovasc Interv 2003;58:406-11. https://doi.org/10.1002/ccd.10401
  12. Pedra CA, Pedra SR, Esteves CA, Pontes SC Jr, Braga SL, Arrieta SR, et al. Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: technical and morphological considerations. Catheter Cardiovasc Interv 2004;61:403-10. https://doi.org/10.1002/ccd.10797
  13. Michel-Behnke I, Le TP, Waldecker B, Akintuerk H, Valeske K, Schranz D. Percutaneous closure of congenital and acquired ventricular septal defects: considerations on selection of the occlusion device. J Interv Cardiol 2005;18:89-99. https://doi.org/10.1111/j.1540-8183.2005.04051.x
  14. Diab KA, Hijazi ZM, Cao QL, Bacha EA. A truly hybrid approach to perventricular closure of multiple muscular ventricular septal defects. J Thorac Cardiovasc Surg 2005;130:892-3.
  15. Michel-Behnke I, Ewert P, Koch A, Bertram H, Emmel M, Fischer G, et al. Device closure of ventricular septal defects by hybrid procedures: a multicenter retrospective study. Catheter Cardiovasc Interv 2011;77:242-51. https://doi.org/10.1002/ccd.22666
  16. Kirklin JK, Castaneda AR, Keane JF, Fellows KE, Norwood WI. Surgical management of multiple ventricular septal defects. J Thorac Cardiovasc Surg 1980;80:485-93.
  17. Griffiths SP, Turi GK, Ellis K, Krongrad E, Swift LH, Gersony WM, et al. Muscular ventricular septal defects repaired with left ventriculotomy. Am J Cardiol 1981;48:877-86. https://doi.org/10.1016/0002-9149(81)90353-2
  18. McDaniel N, Gutgesell HP, Nolan SP, Kron IL. Repair of large muscular ventricular septal defects in infants employing left ventriculotomy. Ann Thorac Surg 1989;47:593-4. https://doi.org/10.1016/0003-4975(89)90441-4
  19. Wollenek G, Wyse R, Sullivan I, Elliott M, de Leval M, Stark J. Closure of muscular ventricular septal defects through a left ventriculotomy. Eur J Cardiothorac Surg 1996;10:595-8. https://doi.org/10.1016/S1010-7940(96)80371-X
  20. Kalra GS, Verma PK, Dhall A, Singh S, Arora R. Transcatheter device closure of ventricular septal defects: immediate results and intermediate-term follow-up. Am Heart J 1999;138(2 Pt 1):339-44. https://doi.org/10.1016/S0002-8703(99)70122-5
  21. Amin Z, Gu X, Berry JM, Bass JL, Titus JL, Urness M, et al. New device for closure of muscular ventricular septal defects in a canine model. Circulation 1999;100:320-8. https://doi.org/10.1161/01.CIR.100.3.320
  22. Fishberger SB, Bridges ND, Keane JF, Hanley FL, Jonas RA, Mayer JE, et al. Intraoperative device closure of ventricular septal defects. Circulation 1993;88(5 Pt 2):II205-9.
  23. Chaturvedi RR, Shore DF, Yacoub M, Redington AN. Intraoperative apical ventricular septal defect closure using a modified Rashkind double umbrella. Heart 1996;76:367-9. https://doi.org/10.1136/hrt.76.4.367
  24. Murzi B, Bonanomi GL, Giusti S, Luisi VS, Bernabei M, Carminati M, et al. Surgical closure of muscular ventricular septal defects using double umbrella devices (intraoperative VSD device closure). Eur J Cardiothorac Surg 1997;12:450-4. https://doi.org/10.1016/S1010-7940(97)00086-9
  25. Bacha EA, Cao QL, Galantowicz ME, Cheatham JP, Fleishman CE, Weinstein SW, et al. Multicenter experience with perventricular device closure of muscular ventricular septal defects. Pediatr Cardiol 2005;26:169-75. https://doi.org/10.1007/s00246-004-0956-2
  26. Lee EM, Roberts DH, Walsh KP. Transcatheter closure of a residual postmyocardial infarction ventricular septal defect with the Amplatzer septal occluder. Heart 1998;80:522-4. https://doi.org/10.1136/hrt.80.5.522
  27. Szkutnik M, Bialkowski J, Chodor P, Banaszak P, Polonski L, Nowak J, et al. Transcatheter closure of a residual postmyocardial infarction ventricular septal defect using Amplatzer atrial septal occluder. Folia Cardiol 2001;8:685-9.
  28. Ruzyllo W, Demkow M, Konka M, Chmielak Z, Wilczynski J, Dzielinska Z, et al. Transcatheter closure of postinfarction ventricular septal defects. Kardiol Pol 2001;54:270-3.
  29. Aitsiselmi A, Bonvini RF, Aggoun Y, Sigwart U. Percutaneous closure of a residual ventricular septal defect in a challenging patient. Acute Card Care 2006;8:21-4. https://doi.org/10.1080/14628840500459898
  30. Neukamm C, Bjornstad PG, Fischer G, Smevik B, Lindberg HL. A novel method of hybrid intraoperative catheter-based closure of ventricular septal defects using the $Amplatzer^{(R)}$ PDA occluder. Catheter Cardiovasc Interv 2011;77:557-63. https://doi.org/10.1002/ccd.22649
  31. El Tahlawi M, Kammache I, Fraisse A. Ventricular septal defect closure in a small children with the Amplatzer Duct Occluder II. Catheter Cardiovasc Interv 2011;77:268-71. https://doi.org/10.1002/ccd.22723

피인용 문헌

  1. Perventricular Device Closure of Congenital Ventricular Septal Defects vol.29, pp.3, 2013, https://doi.org/10.1111/jocs.12334
  2. Longer‐term outcome of perventricular device closure of muscular ventricular septal defects in children vol.85, pp.6, 2013, https://doi.org/10.1002/ccd.25821
  3. Transthoracic Balloon Pulmonary Valvuloplasty for Treatment of Congenial Pulmonary Atresia Patients with Intact Ventricular Septum vol.23, pp.None, 2013, https://doi.org/10.12659/msm.904043
  4. Outcomes Associated with the Off-label Use of Medical Devices in Congenital Heart Disease at a Single Institute vol.47, pp.4, 2017, https://doi.org/10.4070/kcj.2016.0311
  5. Effects of transthoracic device closure on ventricular septal defects and reasons for conversion to open-heart surgery: A meta-analysis vol.7, pp.None, 2013, https://doi.org/10.1038/s41598-017-12500-6
  6. Arterial switch procedure and hybrid muscular ventricular septal defect closure in a patient with d-transposition of the great arteries and multiple ventricular septal defects: a case report and liter vol.29, pp.12, 2019, https://doi.org/10.1017/s1047951119002300